Shareholder Alert: Robbins LLP Informs Investors of the Sarepta Therapeutics, Inc. Class ActionGlobeNewsWire • 06/30/25
SAREPTA THERAPEUTICS, INC. (NASDAQ: SRPT) INVESTOR ALERT: Investors With Large Losses in Sarepta Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsGlobeNewsWire • 06/30/25
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. (SRPT) Investors with Substantial Losses Have Opportunity to Lead the Sarepta Class Action LawsuitGlobeNewsWire • 06/30/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPTGlobeNewsWire • 06/28/25
Rosen Law Firm Urges Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Stockholders with Large Losses to Contact the Firm for Information About Their RightsBusiness Wire • 06/27/25
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sarepta Therapeutics, Inc. (SRPT)GlobeNewsWire • 06/27/25
SRPT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Sarepta Class Action LawsuitBusiness Wire • 06/27/25
Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Sarepta Therapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of August 25, 2025GlobeNewsWire • 06/26/25
SRPT SECURITIES: Lose Money on Sarepta Therapeutics, Inc. (NASDAQ:SRPT)? Contact BFA Law about the Pending Securities Fraud InvestigationGlobeNewsWire • 06/26/25
Sarepta Therapeutics Is Already Down 84% This Year. And The Other Shoe Just Dropped.Investors Business Daily • 06/25/25
SRPT STOCK LOSS: Sarepta Therapeutics, Inc. Shareholders are Alerted of Ongoing Securities Fraud Investigation -- Contact BFA Law (NASDAQ:SRPT)GlobeNewsWire • 06/24/25
SRPT FRAUD ALERT: Sarepta Therapeutics, Inc. Investors are Reminded of Ongoing Securities Fraud Investigation -- Contact BFA Law (NASDAQ:SRPT)GlobeNewsWire • 06/22/25
SRPT INQUIRY: Sarepta Therapeutics, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law (NASDAQ:SRPT)GlobeNewsWire • 06/20/25
SRPT NOTICE: Did Sarepta Therapeutics, Inc. Mislead Investors about the Safety of Elevidys? Contact BFA Law if You Lost Money (NASDAQ:SRPT)GlobeNewsWire • 06/18/25
SRPT BREAKING NEWS: Sarepta Therapeutics, Inc. is being Investigated for Securities Fraud after Second Elevidys Death; Investors with Losses are Notified to Contact BFA LawBusiness Wire • 06/17/25
Sarepta Therapeutics Stock Alert: Investors of Sarepta May Have Legal Claims and Are Encouraged to Contact Kehoe Law Firm, P.C. - SRPTAccesswire • 06/16/25
SRPT Plummets on Second Patient Death After DMD Gene Therapy InfusionZacks Investment Research • 06/16/25